🇺🇸 FDA

Intelligence · Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated — grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≤24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months — use filters for patent-cliff planning.

Page 168 of 173

  1. US 6171855

    Vectors

    Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  2. US 6171788

    Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders

    Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  3. US 6171862

    Transfection in serum-containing media

    Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  4. US 6171856

    Methods and compositions relating to no-mediated cytotoxicity

    Expires Mon Jan 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  5. US 6169074

    Peptide inhibitors of neurotransmitter secretion by neuronal cells

    Expires Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  6. US 6167888

    Method for inducing partial recovery of lost voluntary motor function after spinal cord injury in a mammal

    Expires Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  7. US 6169068

    Pulmonary administration of soluble complement receptor-1 (sCR1) and its derivatives

    Expires Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  8. US 6168779

    Methods and kits for identifying ductal orifices

    Expires Mon Dec 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  9. US 6166079

    DFMO for the treatment or prevention of cervical intraepithelial neoplasia

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  10. US 6165461

    Tao protein kinases and methods of use therefor

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  11. US 6165719

    hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  12. US 6165794

    Suppression of proteolytic activity by dysfunctional protease formation

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  13. US 6165484

    EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  14. US 6165745

    Recombinant production of immunoglobulin-like domains in prokaryotic cells

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  15. US 6165990

    Antisense polynucleotide

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  16. US 6166008

    Treatment of schizophrenia with ampakines and neuroleptics

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  17. US 6166085

    Method of producing analgesia

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  18. US 6166178

    Telomerase catalytic subunit

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  19. US 6166193

    Polynucleotides encoding MY1 receptor

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  20. US 6165440

    Radiation and nanoparticles for enhancement of drug delivery in solid tumors

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  21. US 6166039

    Peripherally active anti-hyperalgesic opiates

    Expires Mon Dec 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  22. US 6162432

    Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction

    Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  23. US 6162900

    Metal-regulated transporters and uses therefor

    Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  24. US 6162641

    Neuregulin response element and uses therefor

    Expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  25. US 6160184

    Total synthesis of antitumor acylfulvenes

    Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  26. US 6159684

    HIV trans-activator TAT binding to CDK7 and activation of CTD phosphorylation

    Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  27. US 6159712

    Methods for enhancing the production of interferon in cell culture

    Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  28. US 6159936

    Compositions and methods for treating and preventing microbial and viral infections

    Expires Mon Dec 07 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  29. US 6156321

    Tissue factor methods and compositions for coagulation and tumor treatment

    Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  30. US 6156879

    Human minor vault protein p193

    Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  31. US 6156723

    Compositions comprising inhibitors of estrogen response

    Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  32. US 6156541

    Compositions and methods for catalyzing hydrolysis of HIV gp120

    Expires Mon Nov 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  33. US 6153200

    Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis

    Expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  34. US 6153194

    Borrelia burgdorferi outer membrane proteins

    Expires Mon Nov 23 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  35. US 6150583

    Transgenic animals expressing artificial epitope-tagged proteins

    Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  36. US 6150395

    Indole-3-carbinol (I3C) derivatives and methods

    Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  37. US 6150345

    Methods for promoting survival of myelin producing cells

    Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  38. US 6149904

    Method for inhibiting tumor cell growth by administering to tumor cells expressing a nucleic acid encoding a connexin and a pro-drug

    Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6149920

    Over-expressing homologous antigen vaccine and a method of making the same

    Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6149931

    Methods and pharmaceutical compositions for the closure of retinal breaks

    Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6149918

    Human herpesvirus type 8 isolated from human lymphoma cell line

    Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6150415

    Epoxide hydrolase complexes and methods therewith

    Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  43. US 6150416

    Nanomolar, non-peptide inhibitors of cathepsin D

    Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  44. US 6150164

    Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo

    Expires Mon Nov 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  45. US 6147123

    Treatment and prevention of hepatic disorders

    Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  46. US 6146628

    Biotherapeutic agents comprising recombinant PAP and PAP mutants

    Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  47. US 6147075

    Alkyl, azido, alkoxy and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist

    Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  48. US 6147191

    Oligodendrocyte-specific protein

    Expires Mon Nov 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.